Aquestive Therapeutics, Inc. (AQST) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.78 | -52.9% |
| 2024 | $-0.51 | -292.3% |
| 2023 | $-0.13 | +88.4% |
| 2022 | $-1.12 | +39.5% |
| 2021 | $-1.85 | -11.4% |
| 2020 | $-1.66 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.78 | -52.9% |
| 2024 | $-0.51 | -292.3% |
| 2023 | $-0.13 | +88.4% |
| 2022 | $-1.12 | +39.5% |
| 2021 | $-1.85 | -11.4% |
| 2020 | $-1.66 | — |